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DexamethasoneAbstract Background and aim: Post-operative pain is considered an important complication of
Intravenous regional anesthesia (IVRA) which is gaining popularity especially for surgeries on
upper limbs.
Methods: The present double blind randomized clinical trial was conducted on 60 candidates of
upper limb surgeries aged between 20 and 60 years who were of ASA classes 1 or 2. Subjects were
randomly assigned to 4 groups: the first group was treated solely with 3 mg/kg of Lidocaine. The
second and third groups received the same amount of Lidocaine plus 8 mg of Dexamethasone or
300 mg of Paracetamol respectively and for the fourth group a combination of all medications was
used. For all patients, Lidocaine was diluted with normal saline until a total volume of 40 cc was
reached. Onset of Sensory and motor nerve blocks, severity of post-operative pain and amount
of mepridine consumption in the first 24 h after surgery were assessed.
Results: Onset of Sensory and motor nerve block was significantly accelerated in the fourth group
(p< 0.01). Post-operative pain and analgesic consumption were significantly reduced in the fourth
group when compared with the other groups (p< 0.05).
Conclusion: A combination of Paracetamol and Dexamethasone significantly enhances the anal-
gesic effect of Lidocaine in IVRA by accelerating the establishment of both the sensory and motor
nerve blocks and prolonging the period of analgesia as well as improving the quality of analgesia
and reducing the need for analgesic medications during and after the operation.
 2015 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Anesthesiologists.
112 M. Noroozi et al.1. Introduction
Many orthopedic surgeries may be performed under nerve
blocks or other alternatives of GA such as Intravenous regio-
nal anesthesia (IVRA). Named after the German Surgeon
August Bier who developed the IVRA or the Bier method in
1908, this technique is still deemed useful for limb surgeries
[1], especially when GA is highly associated with risks such
as difficult intubation or aspiration. The advantages of this
technique include cost effectiveness, rapid achievement of
anesthesia feasibility at a variety of settings such as day case
or the A&E department, desirable site of operation and
reduced risk of hemorrhage [2]. However, this technique is also
associated with a number of untoward reactions which include
toxicity of the local anesthetic agent, obtunded onset of anes-
thesia, fatigue and hypotonia of muscles and the pain of apply-
ing the tourniquet application discomfort and the pain that
afflicts the limb following deflation of the tourniquet [3]. The
anesthetic agent that is to be used in IVRA should ideally yield
short onset, long lasting anesthesia with a low dose and mini-
mal side effects. Efforts are currently underway to optimize the
effect of local anesthetics and minimize their side effects by
using a combination of drugs including opioids such as fen-
tanyl [4,5], Mepridine [6,7], Morphine, Sufentanil and Tra-
madol [1]; NSAIDs such as Ketorolac [1,8], Tenoxicam and
Acetyl Acetate [1]; a2 agonists such as Clonidin [1,9,10] and
Dexmedetomidine [1,11]; Muscle relaxants such as Pancro-
nium [4], Atracurium, cis-Atracurium and Mivacurium [1],
Neostigmin [12,13], Ketamin [14], Magnesium [15] and Bicar-
bonate [1].
Among a host of trials on a wide range of agents to opti-
mize the quality and quantity of anesthesia, some suggest that
addition of Dexamethasone [16] or Paracetamol [17,18] may be
conducive to the effect of Lidocaine in achieving a desirable
state of anesthesia. In the absence of any study to compare
the independent effect of Paracetamol and Dexamethasone
and their combined effect on IVRA with Lidocaine, particu-
larly in the upper limb, and in view of the increasing use of
IVRA for operations in the upper limb, this study was con-
ducted to evaluate the effect of those medications on the depth
and duration of IVR anesthesia in upper limbs.
2. Materials and methods
The present double blind randomized clinical trial was con-
ducted on 60 candidates of upper limb surgeries who were
referred to the Shahid Bahonar Hospital in the city of Kerman.
The study was endorsed by the research council of Kerman
University of Medical Sciences and was approved by its ethical
committee (Ethical code No. k/90/462). Before recruitment of
first subject, study protocol was registered in Iran Registration
of Clinical Trials (IRCT) database under the ID:
IRCT201209053104N2.1
Informed consent was obtained from all subjects who aged
between 20 and 60 years and were of ASA classes 1 or 2. Sub-
jects were randomly assigned to 4 groups: the first group was
treated solely with 3 mg/kg of Lidocaine. The second and third
groups received the same amount of Lidocaine plus 8 mg of1 http://www.irct.ir/searchen.php?keyword=IRCT201209053104N2
&field=a&lang=en.Dexamethasone or 300 mg of Paracetamol respectively and
for the fourth group a combination of all medications was
used. For all patients, Lidocaine was diluted with normal sal-
ine until a total volume of 40 cc was reached. Subjects who
were suspected of any substance or drug abuse, those who were
allergic to Lidocaine or had sustained open fractures of upper
limb or had a history of hepatic disease, those cases who were
complicated by infection and those who had received any other
anesthetic or analgesic medicament prior to the operation were
excluded from the study. Blood pressure, heart rate and arte-
rial oxygen saturation were monitored for all patients in the
operation theater and IV canula was fitted to the healthy limb
of all subjects as a route of fluid or drug administration. Using
a pink venflon, another IV line was secured at the distal end of
the affected limb. After applying Smarch bandage for the pur-
pose of blood evacuation, the limb was elevated for 2 min and
then the proximal tourniquet was inflated to reach a pressure
of 250 mmHg. Medications were administered by an anesthesi-
ologist who was unaware of their content in a period of 90 s.
Then, using a 22 gauge needle, sensory function was evaluated
in the dermatomes pertaining to the Ulnar, Median and Radial
nerves. Motor function was also assessed by flexion and exten-
sion of the wrist and fingers. Absence of any movement was
regarded as completion of motor nerve block. Upon comple-
tion of both sensory and motor nerve blocks, the distal tourni-
quet would be inflated up to 250 mmHg and the proximal
tourniquet would be deflated. Bp, heart rate and arterial O2
saturation readings were recorded before and after application
of the tourniquet as well as at 5, 10, 15, 20, 30, 40 and 50 min
past the start of the operation. The pain that was associated
with tourniquet application was measured by using the Visual
Analog Scale (VAS) at 5, 10, 15, 20, 30, 40 and 50 min after
inflation of the tourniquet. Once the VAS score exceeded 4,
1 lg/kg of Fentanyl would be administered to the patient.
During the surgery, each time the BP dropped to lower than
90 mmHg, it was treated with 5 mg of IV Ephedrin and when
the heart rate dropped to lower than 50 b/min, the patient
would receive 0.5 mg of IV Atropine. At the end of the opera-
tion, an anesthesiologist who was unaware of the group the
patient was assigned to, would label the quality of the patient’s
anesthesia as poor (in need of further analgesia), moderate
(patient often complaining of minor pain but no need for anal-
gesia), Good or Excellent (no complain of pain).
Tourniquets would remain inflated for no shorter than
30 min and no longer than 2 h. Following the deflation of
the tourniquet, the restoration of the sensory function was
assessed every 30 s with the pin prick test. The re-activation
time of the motor function was also recorded once the patient
was able to voluntarily move fingers. For two h past the oper-
ation when the patient was moved to the recovery room or the
ward, he/she was monitored for development of untoward
effects such as Nausea, Vomiting, skin rash, Tachycardia,
bradycardia, Hypotension, hypertension, vertigo, tinnitus
and hypoxia. Any VAS score of higher than 20 was treated
with 4 mg of IV Mepridine.
Based on the results of the Sen et al.’s trial [29], sample size
was calculated by assuming that m1 = 1.8, m2 = 0.2, sd1 = 2,
Sd2 = 1, a= 0.05 and b= 0.8. Accordingly, the size of the
sample was equal to 60. Data analysis was performed by means
of the SPSS 17. The Post Hoc Tukey test and the Repeated
Measure ANOVA were employed for comparing the mean per-
iod of time that was required for the establishment of sensory
Paracetamol, Dexamethasone and Lidocaine in IVRA 113andmotor nerve blocks and the mean VAS scores between the 4
groups of subjects. The quality of anesthesia was compared
between the 4 groups of subjects by means of the chi2 test. Dif-
ferences with P values of less than 0.05 were considered
significant.
3. Results
The 4 groups of subjects were equivalent in terms of age,
height, weight and gender. No significant difference was
observed between the 4 groups in terms of intra operational
BP fluctuation or untoward conditions such as bradycardia,
Hypotension and need for fentanyl administration during the
operation (Table 1).
Mean VAS score during the operation was lowest in the
fourth group (receiving all medications) at 1.84 ± 0.8. This fig-
ure increased from 2.06 ± 0.8 for the 3rd group (Lidocaine
+ Paracetamol) to 2.1 ± 0.9 and 2.7 ± 1.2 for the 2nd and
1st groups respectively. The differences were all statistically
significant (p< 0.05) except for the difference between the
2nd and the 3rd groups (p> 0.05) (Table 2).
Analysis of the mean and SD of VAS scores throughout the
first 24 h past the operation reveals that the highest fluctuation
and thus need for mepridine were in the first 6 h as the VAS
score at 6 h past the operation which pertained to the 4th
group was equal to 3 ± 0.3 and for the 3rd, 2nd and fourth
groups it was equal to 3.4 ± 0.5, 3.3 ± 0.4 and ±0.4 3.8
respectively. These differences were statistically significantTable 1 Demographic particulars and statistical indices of intra op
Group L L +D
Number 15 15
Sex: M/F 8/7 8/7
Age 41.3 ± 3.5 29.1 ±
Weight (kg) 61.6 ± 1.1 70.8 ±
Height (cm) 164.6 ± 1.2 171.6
Mean intra operational systolic BP 132.3 ± 1.8 127.3
Mean intra operational diastolic BP 87.3 ± 0.6 86.2 ±
Mean intra operational heart rate 74.4 ± 0.9 76.9 ±
P> 0.05: no statistically significant difference.
Table 2 Percentage of analgesic requirement and statistical indices o
subjects.
Group L L+ D
VAS (during the operation) 2.7 ± 1.2 2.1 ± 0
VAS (4 h past) 4.6 ± 0.8 3.8 ± 0
VAS (6 h past) 3.8 ± 0.4 3.3 ± 0
VAS (12 h past) 2.7 ± 0.4 2.6 ± 0
VAS (24 h past) 1.4 ± 0.5 1.3 ± 0
VAS (overall 24 h) 3.15 ± 1.3 2.7 ± 1
Percentage of analgesic requirement 73% 60%*
**p< 0.01, *p< 0.05: significant difference with the (L) group.
p< 0.05: difference with the (L + P) group.
Ϯp< 0.05: difference with the (L + P) group.between the 4th group and the other 3 groups and between
the 1st group and both the 2nd and 3rd groups (P< 0.05).
The difference that existed between the 2nd and 3rd groups
in this regard was not statistically significant (P> 0.05).
As depicted in table number 2, the difference between the
VAS scores at 12 and 24 h past the operation was not statisti-
cally significant in all groups.
Mean and SD of the period of time that was required for
the establishment of sensory nerve block (in minutes) were
1.86 ± 0.5, 3.2 ± 0.4, 3.2 ± 0.4 and 5.2 ± 0.7 5.2 for the
4th to 1st groups respectively. The decrease in this index was
statistically significant from the 4th to the other groups
(p< 0.01) and from the 2nd and 3rd groups to the 1st group
(P< 0.001) (Table 3).
The mean and SD of the latency period for the onset of
tourniquet associated pain (in minutes) were 35.4 ± 1.9,
27.8 ± 1.1, 27.6 ± 1.2 and 22 ± 1.6 for the 4th to the 1st
groups respectively which implies a significant increase from
the 1st three groups to the 4th group and from the 1st group
to the 2nd and 3rd groups (p < 0.01) (Table 3).
The mean and SD of the duration of analgesia were 63
± 2.3, 47.6 ± 1.5, 47.9 ± 2.6 and 43 ± 2.3 for the 4th to 1st
groups respectively which again implies a significant increase
from the 1st three groups to the 4th group and from the 1st
group to the 2nd and 3rd groups (p< 0.01) (Table 3).
The quality of anesthesia was also significantly higher in the
4th group as compared to the other groups and in the 2nd and
3rd groups as compared to the first group (P> 0.05) (Fig. 1).erational variables in the 4 groups of subjects.
L + P L+ D+ P P value
15 15
8/7 7/8 P> 0.05
1.7 36.2 ± 3.5 36 ± 3.9 P> 0.05
2.6 68.3 ± 3.3 65.6 ± 3.6 P> 0.05
± 2.4 166.5 ± 2.8 170.5 ± 1.7 P> 0.05
± 4 133 ± 1.4 131.4 ± 2.2 P> 0.05
1.5 84.9 ± 0.4 84 ± 1.1 P> 0.05
1.1 77.6 ± 1.4 79 ± 0.6 P> 0.05
f VAS during the first 24 h past the operation in the 4 groups of
L + P L+D+ P P value
.9* 2.06 ± 0.8* 1.84 ± 0.8**Ϯ
.8* 3.7 ± 0.7* 3.2 ± 0.7**Ϯ
.4* 3.4 ± 0.5* 3 ± 0.3**Ϯ
.5 2.6 ± 0.5 2.5 ± 0.5 P> 0.05
.4 1.2 ± 0.4 1.2 ± 0.4 P> 0.05
.09 2.75 ± 1.09 2.5 ± 0.9 P> 0.05
53%* 40%**Ϯ
Table 3 Comparison of the mean and standard deviation of onset of sensory and motor nerve blocks, Tourniquet associated pain and
duration of anesthesia in the 4 groups of patients.
Group L L +D L+ P L+ D+ P
Onset of sensory block (min) 5.2 ± 0.7 3.2 ± 0.4*** 3.2 ± 0.4*** 1.86 ± 0.5****ϮϮ
Onset of motor block (min) 7.3±0.8 5.3±0.4*** 5.4±0.5*** 3.4±0.5****ϮϮ
Onset of tourniquet associated pain (min) 22 ± 1.6 27.6 ± 1.2** 27.8 ± 1.1** 35.4 ± 1.9***ϮϮ
Duration of anesthesia (min) 43±2.3 47.9±2.6* 47.6±1.5* 63±2.3**Ϯ
***p< 0.001, ****p< 0.0001, **p< 0.01, *p< 0.05: denoting difference with the (L) group.
p<0.01, p< 0.05: denoting difference with the (L+D) group.
ϮϮp< 0.01, Ϯp< 0.05: denoting difference with the (L + P) group.
**p< 0.01ﻭ *p<0.05: Significant difference with the ( L)group
*p<0.05: Difference with the (L+D) group     
p<0/05 Ϯ :   Difference with the (L+P) group     
Figure 1 The quality of analgesia in the 4 groups of patients
that were anesthetized solely with Lidocaine (L), Lidocaine +
Dexamethasone (L + D). Lidocain + Paracetamol (L + P) and
Lidocain + Paracetamol + Dexamethasone (L + P+ D).
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The synergistic effects of Paracetamol as an analgesic and Dex-
amethasone as anti-inflammatory agent in pain suppression,
when combined with other analgesic medications, have been
proved previously in several probes. The present study depicts
a more pronounced analgesic effect for Lidocaine when com-
bined with these two widely used medicines.
As a week inhibitor of prostaglandin synthesis, Paraceta-
mol acts in a similar fashion to selective inhibitors of COX
II; however, it lacks their anti-inflammatory effects [19,20].
Several mechanisms have been proposed for the analgesic
effects of Paracetamol; for instance, Ottani et al. [21] hypoth-
esized that it exerts its effects primarily by modification of
Cannabinoid receptors. In line with this assumption, Antago-
nists of Cannabinoid receptors have been shown to null the
analgesic properties of Paracetamol [22,23]. The recent discov-
ery of COX-3 has suggested a central mechanism for Paraceta-
mol induced analgesia [24,25] which is gaining increasing
popularity for the purpose of pain control [26].In view of the increasing popularity of IVRA, particularly
for upper limb operations, and the necessity of post-operative
pain management, several studies have aimed to strike the
optimal combination of medicaments.
Canbay et al. [27] showed that paracetamol may decrease
the pain at the site of Propophel injection, which is consistent
with the goals of the present study in using the peripheral
antinoceptive effect of paracetamol.
Two other reports by Celik et al. [28] and Sen et al. [29] also
depicted positive results with Adjuvant use of Paracetamol in
IVRA. As implied by the results of the present study, although
both Paracetamol and Dexamethasone effectively lower the
need for post-operative analgesic medication, the difference
in their individual analgesic effect is insignificant. As a Corti-
costeroid, Dexamethasone is a frequently used medicine which
has also been tried individually or in combination with other
drugs for the purpose of reducing post-operative complications
such as nausea and vomiting. A possible explanation for the
benefits of Dexamethasone in controlling post-operative pain
is the fact that acute inflammation due to tissue injury is
believed to be a main cause of post-operative pain. Several
studies have addressed the use of Corticosteroids and Dexam-
ethasone in particular for induction and prolongation of anal-
gesia (16). For example, in a study on 75 candidates of hand
surgery, Bigot et al. [30] showed that Dexamethasone improves
the quality and quantity of analgesia during the first day after
IVRA. No published literature on a controlled trial on com-
paring the individual analgesic effects of Paracetamol and
Dexamethasone as well as their combination was found by
the authors of the present study. The results of the present
study show that a combination of Paracetamol and Dexam-
ethasone significantly enhances the analgesic effect of
Lidocaine in IVRA by accelerating the establishment of both
the sensory and motor nerve blocks and prolonging the period
of analgesia as well as improving the quality of analgesia and
reducing the need for analgesic medications during and after
the operation. Hence, a combination of a specific pain killer
and an anti-inflammatory agent may be considered as the stan-
dard medication in IVRA.
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